Get Smarter About
Stock Investing
Compounding Research delivers insights and cases on undervalued companies to help you grow your wealth.
Built for Individual Investors
For people who are investing their own money into stocks to build long-term wealth… No matter what the market is doing.
About Compounding Research
Most investing today still happens based on stock tickers going up or down.
You get influenced to buy when something is hot… and pressured to sell when it dips.
But deep down, you know that’s not how real wealth is built.
At Compounding Research, Managing Editor Robin Geers focuses on undervalued companies with high upside and limited downside.
Why does Robin have such a track record?
He spends hours digging into balance sheets, earnings calls, and company filings to find businesses most investors overlook.
Each month, Robin publishes a 10-20 page research report on one undervalued company he might invest his own capital in.
He believes wealth is built by investing in companies that are undervalued and that you deeply understand. That’s when you stop speculating and start compounding.
Plus it also helps you sleep better at night, knowing your portfolio holds companies that deserve to grow.
Compounding Research exists to make you a smarter investor through investment insights and cases on undervalued businesses.
Publication overview
How often is this published?
Monthly, with occasional mid-month updates when needed.
How much capital should I have to get started?
At least €5,000 is ideal.
Perfect for long-term investors building a serious portfolio, whether you’re just starting or planning for retirement.
What will we be researching?
Undervalued public companies with long-term upside.
What’s a typical holding period?
3–5 years… ideally forever.
Our goal: buy great companies and let them compound.
Managing Editor
Robin Geers
About The Editor
Robin Geers is the founder and Managing Editor of Compounding Research, a monthly investment publication that researches undervalued companies.
Robin spent years interviewing top entrepreneurs, writing the bestselling book Start-up Survival, and building a successful education company, which he sold to Vlerick Business School.
After selling, he focused on investing his own capital in public companies. His obsession is finding hidden gems that most investors overlook.
Robin’s work has been featured in many European publications, attracting many investors and high-income professionals looking to grow and preserve wealth.
Why subscribe to
Compounding Research?
Real long-term wealth isn’t built by chasing trends, it’s built by owning undervalued businesses that compound over time.
At Compounding Research, Robin doesn't bet on hype or headlines. He digs into balance sheets and earnings calls to find stocks that are mispriced by the market, with the potential to compound for years.
Over the past decade, Robin built a reputation for finding compelling businesses and ignoring 99% of speculative ideas.
Unlike many publishers, Robin doesn’t push out daily research. His discipline is simple: only publish when there’s something truly worth your attention.
Every month, he releases a full research report on one stock he’s considering for his own portfolio. Each report is backed by detailed analysis and helps you skip 50+ hours of research, so you can focus on building smarter portfolios.
Every week, he publishes one investment insight that makes you a smarter investor.
We think that at €15 per month or €150 per year, Compounding Research is one of the best values in investing. If just one idea helps you avoid a bad bet or make a better one, it will pay for itself many times over. That kind of return can compound for generations.
What readers are saying
“I found the free research report really good and genuinely interesting! I had never heard of that company before, but I subscribed immediately and forwarded it to a friend.” - Charles B.
What you get
As a Compounding Research subscriber, you will receive full access to 12 monthly online issues: Every month, Robin will update you with any great opportunities he sees in the market and how best to take advantage.
Compounding Research is ideal for investors seeking undervalued companies with a large margin of safety. All you need to do now is click the button below to get started.